Search Results - Hulot, Jean‐Sébastien

Refine Results
  1. 1
    Pharmacogenomics and personalized medicine: lost in translation?

    Pharmacogenomics and personalized medicine: lost in translation? by Hulot, Jean-Sébastien

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    COVID-19 in patients with cardiovascular diseases

    COVID-19 in patients with cardiovascular diseases by Hulot, Jean-Sébastien

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Gene therapy for the treatment of heart failure: promise postponed

    Gene therapy for the treatment of heart failure: promise postponed by Hulot, Jean-Sebastien, Ishikawa, Kiyotake, Hajjar, Roger J.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Antiplatelet drug interactions with proton pump inhibitors

    Antiplatelet drug interactions with proton pump inhibitors by Scott, Stuart A, Obeng, Aniwaa Owusu, Hulot, Jean-Sébastien

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Assessment of signal quality measured with a smart 12‐lead ECG acquisition T‐shirt

    Assessment of signal quality measured with a smart 12‐lead ECG acquisition T‐shirt by Fouassier, David, Roy, Xavier, Blanchard, Anne, Hulot, Jean‐Sébastien

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies

    Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies by Seguret, Magali, Vermersch, Eva, Jouve, Charlène, Hulot, Jean-Sébastien

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    The Pharmacogenetic Control of Antiplatelet Response: Candidate Genes and CYP2C19

    The Pharmacogenetic Control of Antiplatelet Response: Candidate Genes and CYP2C19 by Yang, Yao, Lewis, Joshua P., Hulot, Jean-Sébastien, Scott, Stuart A.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    2525 Development of human cell-based screening assays to detect subject-specific drug-response variability

    2525 Development of human cell-based screening assays to detect subject-specific drug-response variability by Stillitano, Francesca, Mayourian, Joshua, Dave, Jaydev, Hulot, Jean-Sébastien, Hajjar, Roger J.

    Published 2018
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythmic drugs

    3444 Development of human engineered cardiac tissue (hECT)-based screening assay to explore cardiac contractile properties in response to pharmacological challenge with proarrhythm... by Stillitano, Francesca, Turnbull, Irene C., Dave, Jaydev, Hulot, Jean-Sébastien, Hajjar, Roger J.

    Published 2019
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Multi-ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes

    Multi-ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes by Martis, Suparna, Peter, Inga, Hulot, Jean-Sébastien, Kornreich, Ruth, Desnick, Robert J., Scott, Stuart A.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension

    Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension by Fouassier, David, Blanchard, Anne, Fayol, Antoine, Bobrie, Guillaume, Boutouyrie, Pierre, Azizi, Michel, Hulot, Jean‐Sébastien

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes

    Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes by Hulot, Jean-Sébastien, Stillitano, Francesca, Salem, Joe Elie, Kovacic, Jason C, Fuster, Valentin, Hajjar, Roger J

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Hypoxia promotes a perinatal-like progenitor state in the adult murine epicardium

    Hypoxia promotes a perinatal-like progenitor state in the adult murine epicardium by Sayed, Angeliqua, Turoczi, Szimonetta, Soares-da-Silva, Francisca, Marazzi, Giovanna, Hulot, Jean-Sebastien, Sassoon, David, Valente, Mariana

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Cyclic Nucleotide Compartmentalization: Contributions of Phosphodiesterases and ATP-Binding Cassette Transporters

    Cyclic Nucleotide Compartmentalization: Contributions of Phosphodiesterases and ATP-Binding Cassette Transporters by Cheepala, Satish, Hulot, Jean-Sebastien, Morgan, Jessica A., Sassi, Yassine, Zhang, Weiqiang, Naren, Anjaparavanda P., Schuetz, John D.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors

    Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors by Mirabel, Mariana, Callon, Domitille, Bruneval, Patrick, Lebreil, Anne-Laure, Mousseaux, Elie, Oudard, Stéphane, Hulot, Jean-Sébastien, Andreoletti, Laurent

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis

    Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis by Sanchez-Pena, Paola, Hulot, Jean-Sébastien, Urien, Saïk, Ankri, Annick, Collet, Jean-Philippe, Choussat, Rémi, Lechat, Philippe, Montalescot, Gilles

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

    Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus by Costedoat‐Chalumeau, Nathalie, Amoura, Zahir, Hulot, Jean‐Sébastien, Aymard, Guy, Leroux, Gaëlle, Marra, Donata, Lechat, Philippe, Piette, Jean‐Charles

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases

    Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases by Leroux, Gaëlle, Costedoat‐Chalumeau, Nathalie, Hulot, Jean‐Sébastien, Amoura, Zahir, Francès, Camille, Aymard, Guy, Lechat, Philippe, Piette, Jean‐Charles

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice

    Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice by Hara, Yannis, Sassi, Yassine, Guibert, Christelle, Gambaryan, Natacha, Dorfmüller, Peter, Eddahibi, Saadia, Lompré, Anne-Marie, Humbert, Marc, Hulot, Jean-Sébastien

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19

    PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19 by Scott, Stuart A., Sangkuhl, Katrin, Shuldiner, Alan R., Hulot, Jean-Sébastien, Thorn, Caroline F., Altman, Russ B., Klein, Teri E.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: